Focus Areas
Realizing the potential of Gene Writing
Curing diseases by writing in the code of life
Our Future
At Tessera, we are advancing our Gene Writing™ technology and proprietary LNP delivery system to alter the human genome and effect precise, durable therapeutic change to cure even the most challenging genetic diseases.
We envision a future where we can treat each disease at its source by designing the optimal Gene Writing system for a given disease and delivering therapeutic instructions to the necessary tissue.
Opportunity
Disease Areas
Delivery Method
Initial Focus Tissues
Opportunity
In vivo Rewriting
SNPs, insertions, and deletions
Disease Areas
- Monogenic diseases
- Genetic approaches for prevalent diseases
Delivery Method
Initial Focus Tissues
Opportunity
In vivo Writing
Exon-length sequences or entire genes
Disease Areas
- Monogenic diseases
- Oncology
Delivery Method
Initial Focus Tissues
Opportunity
Ex vivo Writing & Rewriting
Engineered cell therapies
Disease Areas
- Oncology
Delivery Method
Initial Focus Tissues
We are now engineering these natural systems to accomplish clinically meaningful tasks and hopefully develop a suite of effective drugs to cure a range of diseases.
David Davidson
Chief Medical and Development Officer
Meet the leaders of our Gene Writers